Dr. Chu Xie is a researcher at Sun Yat-sen University Cancer Center. He received his PhD training in cancer biology and virology, with a focus on herpesvirus infection, host immune responses, and antibody and vaccine development. His research focuses on Epstein–Barr virus (EBV), Kaposi’s sarcoma-associated herpesvirus (KSHV), and other herpesviruses, particularly viral entry mechanisms, neutralizing antibodies, and nanoparticle vaccines. He has contributed to studies on gammaherpesvirus vaccines, neutralizing antibodies, and the structural and functional characterization of herpesvirus entry proteins. His work aims to advance the understanding of herpesvirus infection and support the development of antibody- and vaccine-based strategies against herpesvirus-associated diseases.